Tarsons Products

376.55
-7.85
(-2.04%)
Market Cap
2,045.20 Cr
EPS
8.01
PE Ratio
68.74
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
543.90
52 Week Low
280.00
PB Ratio
3.25
Debt to Equity
0.44
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from3 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+66.67 %
+66.67 %
Hold
Hold+33.33 %
+33.33 %
Sell
Sell0.0 %
0.0 %

Company News

View All News
Caret
neutral
Tarsons Products Reports Q4 Financial Results2 days ago
Tarsons Products has released its Q4 financial results. The company's revenue increased to 930 million rupees from 866 million rupees year-over-year. EBITDA rose to 370 million rupees from 339 million rupees, with the EBITDA margin improving to 39.73% from 39.1%. However, the standalone net profit decreased to 157 million rupees from 188 million rupees compared to the same period last year.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
2,258.60
#1 23,150.90
68.44
#1 1,434.50
24.59
#1 258
34.21
38.49
383.75
2,052.00
76.78
195.30
19.23
18
-44.16
45.06
376.55
#3 2,045.20
#8 68.74
#2 307.90
#9 -0.45
#2 43
#6 -0.97
47.36
603.45
997.50
58.78
173.30
40.00
15
-34.92
45.16
486.40
585.00
32.21
59.30
30.58
16
6.25
52.35
270.95
433.40
21.62
132.70
#1 61.83
13
-
59.60
163.25
292.30
18.14
65.60
-16.22
4
-
74.40
255.52
250.50
296.76
122.10
19.24
1
159.52
59.08
88.65
164.20
#1 15.97
122.60
16.98
9
45.83
47.15
150.80
151.30
18.92
101.10
0.60
2
#1 841.20
64.63

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
-0.45 %
Net Income Growth
-57.70 %
Cash Flow Change
23.05 %
ROE
-66.13 %
ROCE
-65.83 %
EBITDA Margin (Avg.)
-30.63 %

Quarterly Financial Results

Quarterly Financials
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
62
68
71
77
73
88
65
109
88
108
97
117
Expenses
30
33
32
38
38
41
39
76
66
74
66
76
EBITDA
32
36
39
40
36
47
26
34
22
34
31
41
Operating Profit %
51 %
52 %
53 %
50 %
47 %
52 %
37 %
29 %
22 %
26 %
31 %
33 %
Depreciation
4
3
5
5
5
7
10
12
11
14
17
20
Interest
1
1
1
2
1
0
3
4
4
5
5
5
Profit Before Tax
28
32
33
34
29
39
14
17
6
15
8
16
Tax
7
8
9
9
7
10
4
7
2
5
3
5
Net Profit
21
24
25
25
22
30
10
10
4
10
5
10
EPS in ₹
4.13
4.59
4.88
4.89
4.14
5.69
1.87
1.94
0.75
1.93
0.99
1.92

Balance Sheet

Balance Sheet
2021
2022
2024
Total Assets
296
544
972
Fixed Assets
120
189
336
Current Assets
113
245
235
Capital Work in Progress
22
32
267
Investments
0
0
0
Other Assets
153
323
369
Total Liabilities
296
544
972
Current Liabilities
42
35
213
Non Current Liabilities
10
20
146
Total Equity
244
490
613
Reserve & Surplus
244
479
602
Share Capital
0
11
11

Cash Flow

Cash Flow
2021
2022
2024
Net Cash Flow
-23
75
-47
Investing Activities
-64
-138
-285
Operating Activities
68
84
103
Financing Activities
-27
130
136

Share Holding

% Holding
Aug 2021
Nov 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
50.99 %
47.30 %
47.30 %
47.31 %
47.31 %
47.31 %
47.31 %
47.31 %
47.31 %
47.31 %
47.31 %
47.31 %
47.31 %
47.31 %
47.31 %
47.31 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
8.16 %
7.95 %
8.04 %
7.51 %
9.52 %
DIIs
0.00 %
6.92 %
6.03 %
7.66 %
7.39 %
8.13 %
8.52 %
8.45 %
7.38 %
3.16 %
2.15 %
0.18 %
0.12 %
0.21 %
0.50 %
0.29 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
13.55 %
11.50 %
10.28 %
9.94 %
9.19 %
9.56 %
10.00 %
11.35 %
11.64 %
12.77 %
13.44 %
13.53 %
13.06 %
15.37 %
15.30 %
Others
49.01 %
32.23 %
35.17 %
34.75 %
35.36 %
35.37 %
34.62 %
34.25 %
33.96 %
37.90 %
37.78 %
30.92 %
31.10 %
31.39 %
29.31 %
27.58 %
No of Share Holders
8
61
1,59,891
1,25,714
1,12,227
1,07,011
1,07,945
1,05,304
1,07,440
1,08,236
1,07,564
1,02,866
1,05,330
99,586
96,927
93,417

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.66 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
28 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2025 386.30 431.20
14 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Feb 2025 364.55 329.95
07 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Nov 2024 406.65 419.00
27 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Sept 2024 465.20 452.15
20 Sept 2024 DIVIDEND Dividend
₹ 2.00 /share
20 Sept 2024 418.95 468.70

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication1 day ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome1 day ago
Announcement under Regulation 30 (LODR)-Investor Presentation1 day ago
Announcement under Regulation 30 (LODR)-Change in Management2 days ago
Approved Annual Audited Financial Results For The Year Ended 31St March 20252 days ago
Board Meeting Outcome for Approved The Audited Standalone And Consolidated Financial Results For The Quarter And Financial Year Ended 31St March 20252 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation5 days ago
Announcement under Regulation 30 (LODR)-Change in Directorate5 days ago
Announcement under Regulation 30 (LODR)-Change in Management5 days ago
Announcement under Regulation 30 (LODR)-Resignation of Director5 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation7 days ago
Board Meeting Intimation for Intimation Of Notice Of Board Meeting7 days ago
Compliances-Reg.24(A)-Annual Secretarial Compliance10 days ago
Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015May 07, 2025
Regulation 30 Of SEBI LODR Regulations 2015Apr 09, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Closure of Trading WindowMar 27, 2025
Announcement Under Regulation 30 Of SEBI LODRMar 19, 2025
Announcement Under Regulation 30Feb 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 26, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 20, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 17, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 15, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 15, 2025
Integrated Filing (Financial)Feb 14, 2025
Updates On Outcome Of Board Meeting (Correction Of Inadvertent Typographical Error)Feb 14, 2025
Unaudited Financial Results Of The Company For Third Quarter And Nine-Months Ended 31St December 2024Feb 14, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held For Q3 FY25 Financial ResultsFeb 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 10, 2025
Announcement under Regulation 30 (LODR)-Credit RatingFeb 04, 2025
Board Meeting Intimation for Considering And Approving The Unaudited Standalone & Consolidated Financial Results For The Third Quarter And Nine Months Ended 31St December 2024Jan 31, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 10, 2025
Closure of Trading WindowDec 23, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 29, 2024
Announcement Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015Nov 18, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 13, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 09, 2024
Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015Nov 08, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 08, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationNov 08, 2024
Board Meeting Outcome for Financial Results For Quarter And Half Year Ended 30Th September, 2024Nov 07, 2024
Financial Results For The Quarter & Half Year Ended 30Th September, 2024Nov 07, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 02, 2024
Board Meeting Intimation for Consideration & Approval Of Financial ResultsOct 28, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 09, 2024
Shareholder Meeting - Voting Results Of 41St Annual General MeetingSep 30, 2024
Appointment Of DirectorSep 28, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 28, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 27, 2024
Closure of Trading WindowSep 24, 2024

Technical Indicators

RSI(14)
Neutral
49.69
ATR(14)
Less Volatile
22.72
STOCH(9,6)
Neutral
53.32
STOCH RSI(14)
Oversold
1.05
MACD(12,26)
Bearish
-1.55
ADX(14)
Weak Trend
15.27
UO(9)
Bearish
45.47
ROC(12)
Downtrend But Slowing Down
-1.09
WillR(14)
Oversold
-80.00

Mutual Fund Holdings

Funding HouseNo of SharesCurrent Holding %1M Change %3M Change %Month
Bandhan BSE Healthcare Index Fund Direct-Growth
220
0.04%
0.00%
0.00%
Apr 2025
Bandhan Nifty Total Market Index Fund Direct-Growth
0
0.00%
0.00%
0.00%
Apr 2025
Groww Nifty Total Market Index Fund Direct - Growth
0
0.00%
0.00%
0.00%
Apr 2025
Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth
0
0.00%
0.00%
0.00%
Apr 2025